Clover Health to Report Third Quarter 2024 Financial Results on November 6
Clover Health (Nasdaq: CLOV) announced it will release its third quarter 2024 financial results after market close on Wednesday, November 6, 2024. The company will host a conference call and webcast at 5:00 p.m. Eastern Time the same day to discuss the results. U.S. participants can dial 800-579-2543, while international callers should use 785-424-1789, with conference ID CLOVQ324. The webcast will be available on Clover Health's Investor Relations website for 12 months.
Clover Health (Nasdaq: CLOV) ha annunciato che rilascer脿 i suoi risultati finanziari del terzo trimestre 2024 dopo la chiusura del mercato mercoled矛 6 novembre 2024. L'azienda terr脿 una conferenza telefonica e un webcast alle 17:00 ora orientale dello stesso giorno per discutere i risultati. I partecipanti degli Stati Uniti possono comporre il numero 800-579-2543, mentre i chiamanti internazionali dovrebbero utilizzare il numero 785-424-1789, con ID conferenza CLOVQ324. Il webcast sar脿 disponibile sul sito delle Relazioni con gli Investitori di Clover Health per 12 mesi.
Clover Health (Nasdaq: CLOV) anunci贸 que publicar谩 sus resultados financieros del tercer trimestre de 2024 despu茅s del cierre del mercado el mi茅rcoles 6 de noviembre de 2024. La compa帽铆a llevar谩 a cabo una conferencia telef贸nica y un webcast a las 5:00 p.m. Hora del Este el mismo d铆a para discutir los resultados. Los participantes de EE. UU. pueden marcar el 800-579-2543, mientras que los llamantes internacionales deben usar el 785-424-1789, con el ID de conferencia CLOVQ324. El webcast estar谩 disponible en el sitio web de Relaciones con Inversores de Clover Health durante 12 meses.
Clover Health (Nasdaq: CLOV)電 2024雲 11鞗 6鞚 靾橃殧鞚 鞁滌灔 韽愳灔 頉 2024雲 3攵勱赴 鞛 瓴瓣臣毳 氚滍憸頃 瓴冹澊霛缄碃 氚滍憸頄堨姷雼堧嫟. 須岇偓電 臧欖潃 雮 霃欕秬 響滌鞁 鞓ろ泟 5鞁滊秬韯 瓴瓣臣毳 雲检潣頃橁赴 鞙勴暅 鞝勴檾 須岇潣 氚 鞗轨簮鞀ろ姼毳 歆勴枆頃╇媹雼. 氙戈淡 彀戈皜鞛愲姅 800-579-2543鞙茧 鞝勴檾頃 靾 鞛堨溂氅, 甑牅 鞝勴檾鞛愲姅 785-424-1789鞚 靷毄頃挫暭 頃橂┌, 須岇潣 ID電 CLOVQ324鞛呺媹雼. 鞗轨簮鞀ろ姼電 Clover Health鞚 韴瀽鞛 甏瓿 鞗轨偓鞚错姼鞐愳劀 12臧滌洈 霃欖晥 鞚挫毄頃 靾 鞛堨姷雼堧嫟.
Clover Health (Nasdaq: CLOV) a annonc茅 qu'il publiera ses r茅sultats financiers du troisi猫me trimestre 2024 apr猫s la cl么ture des march茅s le mercredi 6 novembre 2024. L'entreprise organisera un appel conf茅rence et un webcast 脿 17h00, heure de l'Est, le m锚me jour pour discuter des r茅sultats. Les participants am茅ricains peuvent composer le 800-579-2543, tandis que les appelants internationaux doivent utiliser le 785-424-1789, avec l'identifiant de la conf茅rence CLOVQ324. Le webcast sera disponible sur le site des relations avec les investisseurs de Clover Health pendant 12 mois.
Clover Health (Nasdaq: CLOV) hat angek眉ndigt, dass die Finanzergebnisse des dritten Quartals 2024 nach B枚rsenschluss am Mittwoch, den 6. November 2024, ver枚ffentlicht werden. Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen. Teilnehmer aus den USA k枚nnen die Nummer 800-579-2543 w盲hlen, w盲hrend internationale Anrufer 785-424-1789 nutzen sollten, mit der Konferenz-ID CLOVQ324. Der Webcast wird 12 Monate lang auf der Unternehmenswebsite f眉r Investoren von Clover Health verf眉gbar sein.
- None.
- None.
FRANKLIN, Tenn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (鈥淐lover Health鈥), today announced that it will report third quarter 2024 financial results after market close on Wednesday, November 6, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on November 6, 2024, to discuss Clover Health鈥檚 third quarter 2024 business and financial results.
Third Quarter 2024 Conference Call and Webcast Details:
- What: Clover Health鈥檚 Third Quarter 2024 Earnings Conference Call
- When: Wednesday, November 6, 2024, at 5:00 p.m. Eastern Time
- Dial In: To access the call via telephone please dial 800-579-2543 (for U.S. callers) or 785-424-1789 (for callers outside the U.S.) and enter the conference ID: CLOVQ324
- Webcast: A live and archived webcast of the conference call will be accessible from the Investor Relations section of Clover Health鈥檚 website at for 12 months
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we aim to extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology鈥檚 impact on , as well as the earlier identification and management of and .
Press Contact:
Andrew Still-Baxter
Investor Relations Contact:
Ryan Schmidt
FAQ
When will Clover Health (CLOV) report Q3 2024 earnings?
How can I access Clover Health's (CLOV) Q3 2024 earnings call?